12:00 AM
 | 
Nov 16, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ADL7445: Phase I started

Adolor began a single ascending-dose, U.S. Phase I trial to evaluate oral ADL7445 in healthy volunteers. The company also...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >